Health Research

Global TB report; disease continues to be world’s top infectious killer

HQ Team November 15, 2025: Tuberculosis (TB), an ancient disease that has plagued humanity for millennia, remains a formidable global health crisis. Despite.

Read More
Health Research

Stem cell breakthrough reverses osteoporosis in animal studies

HQ Team November 5, 2025: In the fight against osteoporosis, researchers are harnessing the power of stem cells from human fat to regenerate.

Read More
Health Research

COVID-19 infection during pregnancy ups risk of autism in offspring

HQ Team November 3, 2025: New research from Mass General Brigham reveals that children of mothers who had COVID-19 during pregnancy may face.

Read More
Health Research

PSA blood test for prostate cancer cuts death risk by 13%: Study

HQ Team October 31, 2025: A  new study finds that screening for prostate cancer using a simple blood test can significantly reduce the.

Read More
Health Research

Sticky cell breakthrough offers new hope for liver repair without transplants

HQ Team October 30, 2025: For millions of people with severe liver disease, a transplant is the only hope. Now a new discovery.

Read More
Health Research

Ultra-processed food addiction, an overlooked health crisis among older adults

A surprising 12% of older Americans are addicted to ultra-processed foods—a rate that surpasses alcohol or tobacco addiction in this age group. For.

Read More
Drugs Health

HIV’s shape-shifting protein reveals clues for smarter drug design

A study from the Salk Institute has found HIV’s ability to hijack human cells, uncovering a shape-shifting viral protein that could transform treatments for the.

Read More
Drugs Health Pharma

AstraZeneca, Amgen’s drug for nasal inflammation gets EU nod

The European Union approved AstraZeneca Plc and Amgen Inc.’s add-on therapy to treat adults with a chronic inflammatory condition of the nasal passages.

Read More
Drugs Health Pharma

China’s Innovent, Japan’s Takeda in $11.4 billion deal for cancer therapies

China’s Innovent Biologics and Takeda Pharmaceutical Co. announced a $11.4 billion licensing deal, which will enable the former to speed up the development.

Read More
Drugs Health Pharma

Asset managers Blackstone, TGP to acquire Hologic for $18.3 billion

Hologic Inc., which specialises in women’s health diagnostics, is set to be acquired in a deal worth $18.3 billion backed by asset managers.

Read More